World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
75
Citations
20304
World Ranking
2018
National Ranking
967

Todd W. Vanderah publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Todd W. Vanderah sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 260 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Todd W. Vanderah D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Todd W. Vanderah sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 75 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Todd W. Vanderah is affiliated with the University of Arizona in the United States and has contributed extensively to research in the fields of Medicine and Neuroscience. Their work spans various subfields including Cellular and Molecular Neuroscience, Pharmacology, Physiology, Molecular Biology, and Psychiatry and Mental Health.

Their research focuses on topics such as Cannabis and Cannabinoid Research, Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior, Musculoskeletal Pain and Rehabilitation, Pain Mechanisms and Treatments, Neuroscience of Respiration and Sleep, and Ion Channel Regulation and Function.

Frequent collaborators in their research efforts include Tally M. Largent-Milnes, Erika Liktor-Busa, Paul R. Langlais, Jennifer S. De La Rosa, and Mohab Ibrahim.

Their recent scholarly contributions include the following papers:

  • Co-occurrence of chronic pain and anxiety/depression symptoms in U.S. adults: prevalence, functional impacts, and opportunities (2023, Pain)
  • Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents (2021, Science Translational Medicine)
  • Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats (2021, Biology of Sex Differences)
  • Chronic Morphine-Induced Changes in Signaling at the A3 Adenosine Receptor Contribute to Morphine-Induced Hyperalgesia, Tolerance, and Withdrawal (2020, Journal of Pharmacology and Experimental Therapeutics)
  • The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain (2020, Journal of Pharmacology and Experimental Therapeutics)

Todd W. Vanderah has published frequently in venues such as the Journal of Pain, Pain, bioRxiv (Cold Spring Harbor Laboratory), Journal of Pharmacology and Experimental Therapeutics, and Frontiers in Pharmacology.

Best Publications

  • CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.

    Mohab M. Ibrahim;Frank Porreca;Josephine Lai;Phillip J. Albrecht

  • Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

    Mohab M. Ibrahim;Hongfeng Deng;Alexander Zvonok;Debra A. Cockayne

  • Unmasking the tonic-aversive state in neuropathic pain.

    Tamara King;Louis Vera-Portocarrero;Tannia Gutierrez;Todd W Vanderah

  • CB2 cannabinoid receptor-mediated peripheral antinociception.

    T.Philip Malan;Mohab M. Ibrahim;Hongfeng Deng;Qian Liu

  • AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties

    Narender R. Gavva;Rami Tamir;Yusheng Qu;Lana Klionsky

  • Molecular Determinants of Vanilloid Sensitivity in TRPV1

    Narender R. Gavva;Lana Klionsky;Yusheng Qu;Licheng Shi

  • Distinct potassium channels on pain-sensing neurons

    Matthew N. Rasband;Eunice W. Park;Todd W. Vanderah;Josephine Lai

  • Dynorphin Promotes Abnormal Pain and Spinal Opioid Antinociceptive Tolerance

    Todd W. Vanderah;Luis R. Gardell;Shannon E. Burgess;Mohab Ibrahim

  • Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain.

    Shannon E. Burgess;Luis R. Gardell;Michael H. Ossipov;T. Philip Malan

  • Tonic Descending Facilitation from the Rostral Ventromedial Medulla Mediates Opioid-Induced Abnormal Pain and Antinociceptive Tolerance

    Todd W. Vanderah;Nova M. H. Suenaga;Michael H. Ossipov;T. Philip Malan

  • Regular exercise reverses sensory hypersensitivity in a rat neuropathic pain model: role of endogenous opioids.

    Nicola J. Stagg;Heriberto P. Mata;Mohab M. Ibrahim;Erik J. Henriksen

  • Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin.

    Todd W. Vanderah;Michael H. Ossipov;Josephine Lai;T.Philip Malan

  • Pronociceptive actions of dynorphin maintain chronic neuropathic pain.

    Zaijie Wang;Luis R. Gardell;Michael H. Ossipov;Todd W. Vanderah

  • Peripheral mechanisms of pain and analgesia

    Christoph Stein;J. David Clark;Uhtaek Oh;Michael R. Vasko

  • Preclinical Assessment of Candidate Analgesic Drugs: Recent Advances and Future Challenges

    S. Stevens Negus;Todd W. Vanderah;Michael R. Brandt;Edward J. Bilsky

  • Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.

    A Mattia;T Vanderah;H I Mosberg;F Porreca

  • Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers.

    Luis R. Gardell;Ruizhong Wang;Shannon E. Burgess;Michael H. Ossipov

  • Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure.

    Michael H. Ossipov;Josephine Lai;Tamara King;Todd W. Vanderah

  • Inhibition of Neuropathic Pain by Selective Ablation of Brainstem Medullary Cells Expressing the μ-Opioid Receptor

    Frank Porreca;Shannon E. Burgess;Luis R. Gardell;Todd W. Vanderah

  • Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.

    Aline Quartilho;Heriberto P. Mata;Mohab M. Ibrahim;Todd W. Vanderah

Frequent Co-Authors

Frank Porreca
Frank Porreca University of Arizona
Victor J. Hruby
Victor J. Hruby University of Arizona
Michael H. Ossipov
Michael H. Ossipov University of Arizona
Tamara King
Tamara King University of New England
Henry I. Yamamura
Henry I. Yamamura University of Arizona
T. Philip Malan
T. Philip Malan University of Arizona
Rajesh Khanna
Rajesh Khanna University of Florida
Alexandros Makriyannis
Alexandros Makriyannis Northeastern University
Gregory Dussor
Gregory Dussor The University of Texas at Dallas
Patrick W. Mantyh
Patrick W. Mantyh University of Arizona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in neuroscience opens doors to a variety of related fields, many of which offer flexible online learning options. For students interested in mental health or clinical social work, pursuing online msw programs can be a strategic choice. These programs often lead to impactful clinical roles in healthcare settings.

If your passion lies in behavioral science or applied behavioral analysis, exploring bcba certification programs can help you qualify for roles working with individuals on the autism spectrum and others with developmental needs. These programs are designed to be accessible and affordable for working professionals.

For those looking to accelerate their education, consider one of the one year msw programs, which allow students to complete a master’s degree in social work at a faster pace. Similarly, an accelerated bachelor's degree psychology enables you to fast-track your entry into various roles across neuroscience, research, and mental health.

These pathways offer diverse opportunities for those studying neuroscience and can be tailored to fit your individual career goals and timelines.

Best Scientists Citing Todd W. Vanderah

Trending Scientists

Recently Published Articles